NCT06128694 2024-07-30
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
Phase 3 Unknown
Clinical Trials
651 trialsNCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT04547634 2024-06-04
Telerehabilitation in Oncology Patients
University of Malaga
Phase NA Unknown
NCT06291688 2024-03-04
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
National Taiwan University Hospital
Phase NA Unknown
NCT05763355 2024-02-28
BIOPROSTABORD
Elsan
Phase NA Unknown
NCT06279767 2024-02-28
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2 Unknown
NCT06075849 2024-02-23
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Phase 1 Unknown
NCT06275321 2024-02-23
Physical Exercise Benefits for Cancer Patients
Universitat Jaume I
Phase NA Unknown
NCT05591053 2024-02-21
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Activ Surgical
Phase NA Unknown
NCT01860365 2024-02-20
Measuring Concerns of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within Oncology Service
Carmel Medical Center
Phase NA Unknown
NCT04145388 2024-02-14
Family History Study on Cancer Risk
Kaiser Permanente
Phase NA Unknown
NCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT06254989 2024-02-12
ESAP-CS
Holy Name Medical Center, Inc.
Phase NA Unknown
NCT03549273 2024-02-07
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Phase 2 Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT05598827 2024-02-07
Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy
Henan Cancer Hospital
Phase NA Unknown
NCT05433636 2024-02-06
Mindful Waiting Room
University of Utah
Phase NA Unknown
NCT05991544 2024-01-31
The Effect of Training and Follow-up Given to Cancer Patients Receiving Chemotherapy According to the Neuman Systems Model on the Development of Oral Mucositis and Perceptions of Comfort in Patients
Ataturk University
Phase NA Unknown
NCT05675605 2024-01-30
A Study of TY-1091 in Patients With Advanced Solid Tumors
TYK Medicines, Inc
Phase 1/2 Unknown
NCT06224894 2024-01-25
The Effect of Music Therapy on Nausea, Vomiting and Anxiety Levels in Children
Bilecik Seyh Edebali Universitesi
Phase NA Unknown
NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown
NCT06173011 2024-01-23
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT06186427 2024-01-22
68Ga-GPFAPI
Guangdong Provincial People's Hospital
Phase NA Unknown
NCT05229029 2024-01-19
TCM
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT01481532 2024-01-17
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Celtic Biotech Ltd
Phase 1 Unknown
NCT05191641 2024-01-17
Effect of Individualized Nursing Care for Parents of Pediatric Oncology Patients
Akdeniz University
Phase NA Unknown
NCT06203301 2024-01-12
The Relationships of Resistance Exercise, Walking, Myokine Secretion, Sarcopenia, Muscle Loss, Quality of Life, and Predictors in Cancer Patients Receiving Chemoradiotheray
Taipei Medical University
Phase NA Unknown
NCT06174532 2023-12-27
Virtual Surgical Planning in Mandibular Segmental Resection
University of Medicine and Pharmacy at Ho Chi Minh City
Phase NA Unknown
NCT06175780 2023-12-26
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Phase 1 Unknown
NCT05501990 2023-12-21
Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
Ruijin Hospital
Phase NA Unknown
NCT06176274 2023-12-19
Pre-Operative Prehabilitation Program Women With Gynecological Cancer
Istanbul University - Cerrahpasa
Phase NA Unknown
NCT03935256 2023-12-18
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
Loyola University
Phase 2 Unknown
NCT02879864 2023-12-15
EFFLUX
Fondation Hôpital Saint-Joseph
Phase NA Unknown
NCT05150236 2023-12-15
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
NCT04686851 2023-12-13
PROGNOSIS-RCT
Odense University Hospital
Phase NA Unknown
NCT02469129 2023-12-12
PET Imaging of PARP Activity in Cancer
Washington University School of Medicine
Phase EARLY_PHASE1 Unknown
NCT03660670 2023-12-12
ONCORAL-PRME
Hospices Civils de Lyon
Phase NA Unknown
NCT02871856 2023-12-05
ILST
The University of Queensland
Phase NA Unknown
NCT05816369 2023-12-04
Oral Nutritional Supplement Preferences in Patients With Cancer
University of Bergen
Phase NA Unknown
NCT05068869 2023-12-01
Digital Outpatient Services
Oslo University Hospital
Phase NA Unknown
NCT05409352 2023-11-28
Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy
The University of Hong Kong
Phase NA Unknown
NCT06147362 2023-11-27
68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study
Karolinska University Hospital
Phase 1 Unknown
NCT05784766 2023-11-22
SARIC
University of Oklahoma
Phase NA Unknown
NCT04758650 2023-11-18
MITRAS
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT06126705 2023-11-13
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
Affiliated Hospital of North Sichuan Medical College
Phase EARLY_PHASE1 Unknown
NCT04343859 2023-11-09
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Tianjin Chasesun Pharmaceutical Co., LTD
Phase 1 Unknown
NCT05311709 2023-11-09
SOLUCOM
Vestre Viken Hospital Trust
Phase 2 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT06035263 2023-11-02
Effects of a Functional Re-education and Environmental Adaptation Programme in Cancer Patients With Associated Respiratory Pathology
University of Salamanca
Phase NA Unknown
NCT06103279 2023-10-26
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Ain Shams University
Phase 2/3 Unknown